The use of psychoeducation for a patient with hepatitis C and psychiatric illness in preparation for antiviral therapy: A case report and discussion

Journal of Clinical Psychology in Medical Settings

Volumn 18, Issue 1, 2011, Pages 99-107

  Hong, Barry A ^a   North, Carol S ^b   Pollio, David E ^d   Abbacchi, Anna ^a   Debold, Christine ^a   Adewuyi, Sunday A ^c   Lisker Melman, Mauricio ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF ALABAMA   (United States)

Author keywords

Antiviral therapy; Hepatitis C; Psychiatric illness; Psychoeducation

Indexed keywords

ANTIHYPERTENSIVE AGENT; CITALOPRAM; LORAZEPAM; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; TRAZODONE;

ADULT; ALCOHOLISM; ANTIVIRAL THERAPY; ARTICLE; CASE REPORT; DOCTOR PATIENT RELATION; HEPATITIS C; HOSTILITY; HUMAN; HUMAN TISSUE; HYPERTENSION; MAJOR DEPRESSION; MALE; MENTAL DISEASE; PERSONAL EXPERIENCE; PRIORITY JOURNAL; PSYCHOEDUCATION; PSYCHOPHARMACOTHERAPY; RELAPSE; SEIZURE; SUICIDAL IDEATION; VIRUS LOAD;

ADAPTATION, PSYCHOLOGICAL; ALCOHOLISM; ANTIVIRAL AGENTS; AWARENESS; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; MALE; MENTAL DISORDERS; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PROBLEM SOLVING; PSYCHOTHERAPY; PSYCHOTHERAPY, GROUP; RECURRENCE; RIBAVIRIN; SOCIAL SUPPORT; SUBSTANCE ABUSE, INTRAVENOUS; SUICIDAL IDEATION;

EID: 79953023931     PISSN: 10689583     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10880-011-9227-6     Document Type: Article

References (33)

1. S Bonaccorso V Marino M Biondi F Grimaldi F Ippoliti M Maes 2002 Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus Journal of Affective Disorders 72 237 241 12450640 10.1016/S0165-0327(02)00264-1 1:CAS:528:DC%2BD38XovFGmu7w%3D (Pubitemid 35351283)
2. Brau, N. (2002). Pegylated Interferons and Advances in Therapy for Chronic Hepatitis C. Medscape. http://www.medscape.com/viewproqram/2035pnt. Accessed 11/1/02.
3. B Broers B Helbling A Franc P Schmid C Chuard A Hadengue F Negro 2005 Barriers to interferon-A therapy are higher in intravenous drug users than in other patients with acute hepatitis C Journal of Hepatology 42 323 328 15791696 10.1016/j.jhep.2004.11.018 1:CAS:528:DC%2BD2MXhtlensro%3D (Pubitemid 40254245)
4. P Cacoub E Rosenthal P Halfon D Sene C Perronne S Pol 2006 Treatment of hepatitis C virus and human immunodeficiency virus coinfection: From large trials to real life Journal of Viral Hepatitis 13 678 682 16970599 10.1111/j.1365-2893.2006.00740.x 1:STN:280:DC%2BD28rks1Cntg%3D%3D (Pubitemid 44401196)
5. Cawthorne, C. H., Rudat, K. R., Burton, M. S., Brown, K. E., Luxon, B. A., Janney, C. G., et al. (2002). Limited success of HCV antiviral therapy in United States veterans. American Journal of Gastroenterology, 97, 149-155. (Pubitemid 34059779)
6. T Chen EL Ding GR Seage AY Kim 2009 Meta-analysis: Increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression HIV/AIDS 49 1605 1615
7. J Delwaide R El Saouda C Gérard J Belaïche the Groupe Liègeois d'Etude des Virus Hépatotropes 2005 Hepatitis C infection: Eligibility for antiviral therapies European Journal of Gastroenterology and Hepatology 17 1185 1189 16215430 10.1097/00042737- 200511000-00006 (Pubitemid 41527435)
8. E Dieperink M Willenbring SB Ho 2000 Neuropsychiatric symptoms associated with hepatitis C and Interferon alpha: A review American Journal of Psychiatry 157 867 876 10831463 10.1176/appi.ajp.157.6.867 1:STN:280:DC%2BD3c3pt1Ogtg%3D%3D (Pubitemid 30412335)
9. GJ Dore M Hellard GV Matthews J Grebely S Paul PS Haber K Kathy Petoumenos B Barbara Yeung P Philippa Marks I Van Ingrid Beek G Geoffrey Mccaughan P Peter White R Rosemary French W William Rawlinson R Andrew AR Lloyd JM Kaldor 2010 Clinical-Liver, pancreas, and biliary tract Gastroenterology 138 123 135 19782085 10.1053/j.gastro.2009.09.019
10. Y Falck-Ytter H Kale KD Mullen SA Sarbah L Sorescu AJ McCullough 2002 Surprisingly small effect of antiviral treatment in patients with hepatitis C Annals of Internal Medicine 136 288 292 11848726 1:CAS:528:DC%2BD38XhvF2ktLo%3D (Pubitemid 34150758)
11. CA Fleming S Tumilty JE Murray D Nunes 2005 Challenges in the treatment of patients coinfected with HIV and hepatitis C virus: Need for team care Clinical Infectious Diseases 40 S349 S354 15768347 10.1086/427452 (Pubitemid 40490224)
12. RJ Fontana CA Moyer S Sonnad ASF Lok N Sneed-Pee J Walsh S Klein S Webster 2001 Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C American Journal of Gastroenterology 96 170 178 11197249 10.1111/j.1572-0241.2001.03473.x 1:STN:280: DC%2BD3M7gslGiuw%3D%3D (Pubitemid 32104825)
13. K Freedman J Nathanson 2009 Interferon-based hepatitis C treatment in patients with pre-existing severe mental illness and substance abuse disorders Expert Review of Anti-Infective Therapy 7 363 376 19344248 10.1586/eri.09.1 1:CAS:528:DC%2BD1MXktV2ntLs%3D
14. J Grebely KA Genoway JD Raffa G Dhadwal T Rajan G Showler K Kalousek F Duncan MW Tyndall C Fraser B Conway B Fischer 2008 Barriers associated with the treatment of hepatitis C virus infection among illicit drug users Drug and Alcohol Dependence 93 141 147 17997050 10.1016/j.drugalcdep.2007.09.008 (Pubitemid 350245718)
15. J Grebely E Knight KA Genoway M Viljoen M Khara D Elliott L Gallagherb M Storms JD Raffa S De Vlaming F Duncan B Conway 2010 Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: A novel model incorporating multidisciplinary care and peer support European Journal of Gastroenterology and Hepatology 22 270 277 20425880 10.1097/MEG.0b013e32832a8c4c
16. CS Hall ED Charlebois JA Hahn AR Moss DR Bangsberg 2004 Hepatitis C virus infection in San Francisco's HIV-infected urban poor Journal of General Internal Medicine; 19 357 365 15061745 10.1111/j.1525-1497.2004.30613.x (Pubitemid 38530507)
17. SB Ho H Nguyen LL Tetrick, et al. 2001 Influence of psychiatric diagnoses on interferon-alpha treatment for chronic hepatitis C in a veteran population American Journal of Gastroenterology 96 157 164 11197246 1:CAS:528: DC%2BD3MXhtFKjsrk%3D (Pubitemid 32104824)
18. MR Kraus A Schafer H Faller H Csef M Scheurlen 2003 Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy Journal of Clinical Psychiatry 64 708 714 12823087 10.4088/JCP.v64n0614 (Pubitemid 36750150)
19. TJ Liang 1998 Combination therapy for hepatitis C infection New England Journal of Medicine 339 1549 1550 9819457 10.1056/NEJM199811193392112 1:STN:280:DyaK1M%2FisFemtQ%3D%3D (Pubitemid 28543507)
20. I Maida V Soriano B Ramos P Ríos J González-Lahoz M Núñez 2005 Characteristics and prospects for hepatitis C therapy of an HIV-HCV coinfected population followed at a reference HIV center HIV Clinical Trials 6 329 336 16452066 10.1310/25KL-0VTL-JWXP-FE6Y (Pubitemid 43336967)
21. McLaren, M., Garber, G., & Cooper, C. (2008). Barriers to hepatitis C virus treatment in a Canadian HIV-Hepatitis C virus coinfection tertiary care clinic. Canadian Journal of Gastroenterology, 22, 133-137. (Pubitemid 351566106)
22. SH Mehta BL Genberg J Astemborski R Kavasery GD Kirk D Vlahov SA Strathdee DL Thomas 2008 Limited uptake of hepatitis C treatment among injection drug users Journal of Community Health 33 126 133 18165889 10.1007/s10900-007- 9083-3
23. National Institute on Alcohol Abuse and Alcoholism. (1999). PAS-99-155: Hepatitis C infection and alcoholic liver disease. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism.
24. National Institutes of Health 2002 National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002-June 10-12, 2002 Hepatology 36 S3 S20
25. CS North DE Pollio B Sachar B Hong K Isenberg G Bufe 1998 The family as caregiver: A group psychoeducation model for schizophrenia American Journal of Orthopsychiatry 68 39 46 9494640 10.1037/h0080268 1:STN:280:DyaK1c7lsFOntg%3D%3D (Pubitemid 28078445)
26. PF Renault JH Hoofnagle Y Park KD Mullen M Peters DB Jones V Rustgi EA Jones 1987 Psychiatric complications of long-term interferon alfa therapy Archives of Internal Medicine 147 1577 1580 3307672 10.1001/archinte.147.9.1577 1:STN:280:DyaL2szisFejsw%3D%3D (Pubitemid 17138838)
27. MA Rifai 2006 Ethical impasses in the care of patients with hepatitis C Psychosomatics 47 540 541 17116963 10.1176/appi.psy.47.6.540 (Pubitemid 44657612)
28. GB Schreiber MP Busch SH Kleinman JJ Korelitz 1996 The risk of transfusion-transmitted viral infections The Retrovirus Epidemiology Donor Study New England Journal of Medicine 334 1685 1690 8637512 10.1056/ NEJM199606273342601 1:STN:280:DyaK283ktVGhug%3D%3D (Pubitemid 26193619)
29. KH Seal SL Currie H Shen BS Anand EJ Bini N Brau L Jeffers TL Wright 2007 Hepatitis C treatment candidacy and outcomes among 4318 US veterans with chronic hepatitis C virus infection: Does a history of injection drug use matter? Clinical Gastroenterology 41 199 205 10.1097/01.mcg.0000212644.82853.51 (Pubitemid 46148663)
30. D Spiegel JR Bloom I Yalom 1981 Group support for patients with metastatic cancer A randomized outcome study Archives of General Psychiatry 38 527 533 7235853 1:STN:280:DyaL3M3gs1Citw%3D%3D (Pubitemid 11121060)
31. H Thein Q Yi GJ Dore MD Krahn 2008 Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: A meta-analysis AIDS 22 1979 1991 18784461 10.1097/QAD.0b013e32830e6d51
32. VV Thompson KE Ragland CS Hall M Morgan DR Bangsberg 2005 Provider assessment of eligibility for hepatitis C treatment in HIV-infected homeless and marginally housed persons AIDS 19 S208 S214 16251820 10.1097/01.aids. 0000192091.38883.f9
33. SP Yovtcheva MA Rifai JK Moles BJ Van der Linden 2001 Psychiatric comorbidity among hepatitis C positive patients Psychosomatics 42 411 415 11739908 10.1176/appi.psy.42.5.411 1:STN:280:DC%2BD3Mnpt1ylsQ%3D%3D (Pubitemid 33032113)